Regression of cyclosporine A-induced gingival hyperplasia following switch to tacrolimus in renal transplant recipients

Advances in Clinical and Experimental Medicine

Volumn 14, Issue 1, 2005, Pages 69-73

  Radwan Oczko, Małgorzata ^a   Boratyńska, Maria ^a   Banasik, Mirosław ^a   Klinger, Marian ^a   Zietek, Marek ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cyclosporine A; Gingival hyperplasia; HLA DR antigens; Renal transplantation; Tacrolimus

Indexed keywords

AMLODIPINE; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; HLA ANTIGEN; HLA DR2 ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; VERAPAMIL;

ADULT; ALLELE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; FEMALE; GENDER; GINGIVA HYPERPLASIA; GINGIVA OVERGROWTH; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; RECIPIENT; REMISSION; RISK FACTOR;

EID: 16244368509     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Pan WL, Chan CP, Huang CC, Lai MK, Ju YR, Hsueh Ch: Primary extramedullary plasmocytoma in cyclosporine induced gingival overgrowth. J Periodontol 1995, 66, 804-807.
2. Pernu HE, Knuuttila ML, Huttunen KRH, Tiilikainen ASK: Drug-induced gingival overgrowth and class II major histocompatibility antigens. Transplantation 1994, 57,1811-1823.
3. Margiotta V, Pizzo I, Pizzo G, Barbaro A: Cyclosporin and nifedipine-induccd gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters, and HLA-antigens. J Oral Pathol Med 1996, 25, 128-134.
4. Morgan JDT, Swarbrick MJ, Edwards CM, Donnelly PK: Cyklosporin, nifedipine and gingival hyperplasia: a randomized controlled study. Transpl Int 1994, 7, Suppl. 1, 320-321.
5. Kohnle M, Lütkes P, Witzke O, Philipp T, Heemann U: Conversion to Tacrolimus in Cyclosporin A Treated Patients with Gum Hyperplasia. Transplant Proc 1998, 30, 2122-2123.
6. Thorp M, DeMattos A, Bennett W, Barry J, Norman D: The Effect of Conversion from Cyclosporine to Tacrolimus on Gingival Hyperplasia, Hirsutyzm and Cholesterol. Transplantation 2000, 69, 1218-1224.
7. Pretagostini R, Rossi M, Colonnello M, Novelli G, Berloco P, Venettoni S, Cortesini R: Conversion from Cyclosporin to Tacrolimus in Chronic Allograft Nephropathy. Transplant Proc 2001, 33, 1025-1026.
8. Pernu HE, Pernu LM, Knuuttila ML, Huttunen KRH: Gingival overgrowth among renal transplant recipients and uremic patients. Nephrol Dial Transplant 1993, 8, 1254-1258.
9. Thomas DW, Newcombe RG, Osborne GR: Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 2000, 27, 522-526.
10. Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G, Dark J, Idle JR: Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995, 66, 742-746.
11. Thomason JM, Seymour RA, Ellis JS: Determinants of gingival overgrowth severity in organ transplant patients. An examination of the role of HLA phenotype. J Clin Periodontol 1996, 23, 628-634.
12. Thomason JM, Kelly PJ, Seymour RA: The distribution of gingival overgrowth in organ transplant patients. J Clin Periodontol 1996, 23, 367-371.
13. Cebeci I, Kantarci A, Firatli E, Carin M., Tuncer O: The effect of verapamil on the prevalence of cyclosporine induced gingival overgrowth in renal allograft recipients. J Periodontol 1996, 67, 1201-1205.
14. 1. J Periodont Res 1998, 33, 40-48.